Muzastotug is under clinical development by Adagene Suzhou and currently in Phase II for Hepatocellular Carcinoma.

Tevimbra is under clinical development by BeiGene and currently in Phase III for Hepatocellular Carcinoma. According to GlobalData, Phase III drugs for Hepatocellular Carcinoma have a 47% phase ...

Transarterial chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma (HCC). The optimal schedule, best anticancer agent and best technique are still unclear.

Background: Hepatoblastoma (HBL) and hepatocellular carcinoma (HCC) are respectively the first and the second most common pediatric malignant liver tumors. The purpose of this study was to ...

The following is a summary of “Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of ...

There’s a stigma surrounding liver cancer. Once you tell people you’ve got it, often you sense a slight judgment. “Oh”, you ...

North Carolina construction worker Derek Barnett, 55, lost more than 70 pounds on a unique nutrition and fitness journey ...

The Barbara Ann Karmanos Cancer Institute in Detroit says the new TheraBionic P1 device, an FDA-approved, at-home treatment, ...

Scientists at University of California San Diego School of Medicine have shed new light on the development of liver cancer, ...

Institute of Biochemistry and Genetics Russian Academy of Science (IBG RAS) of the Ufa Federal Research Centre, Oktyabrya Prospekt 71, Ufa 450054, Russian Federation Moscow Institute of Physics and ...

Scientists have revealed new insights into the origin of liver cancer and, more broadly, on the effects of a high-fat diet on our DNA.